203 related articles for article (PubMed ID: 38278150)
41. ATP and Its Metabolite Adenosine as Regulators of Dendritic Cell Activity.
Silva-Vilches C; Ring S; Mahnke K
Front Immunol; 2018; 9():2581. PubMed ID: 30473700
[TBL] [Abstract][Full Text] [Related]
42. The degree of T cell stemness differentially impacts the potency of adoptive cancer immunotherapy in a Lef-1 and Tcf-1 dependent manner.
Rangel Rivera GO; Dwyer CJ; Knochelmann HM; Smith AS; Aksoy A; Cole AC; Wyatt MM; Thaxton JE; Lesinski GB; Paulos CM
bioRxiv; 2023 Mar; ():. PubMed ID: 36945574
[TBL] [Abstract][Full Text] [Related]
43. Adenosine production by human B cells and B cell-mediated suppression of activated T cells.
Saze Z; Schuler PJ; Hong CS; Cheng D; Jackson EK; Whiteside TL
Blood; 2013 Jul; 122(1):9-18. PubMed ID: 23678003
[TBL] [Abstract][Full Text] [Related]
44. Unconventional, adenosine-producing suppressor T cells induced by dendritic cells exposed to BPZE1 pertussis vaccine.
Fedele G; Sanseverino I; D'Agostino K; Schiavoni I; Locht C; Horenstein AL; Malavasi F; Ausiello CM
J Leukoc Biol; 2015 Oct; 98(4):631-9. PubMed ID: 26089537
[TBL] [Abstract][Full Text] [Related]
45. Adenosine triphosphate degradation products after oxidative stress and metabolic dysfunction in cultured retinal cells.
Rego AC; Santos MS; Oliveira CR
J Neurochem; 1997 Sep; 69(3):1228-35. PubMed ID: 9282947
[TBL] [Abstract][Full Text] [Related]
46. Expression of ADK-S and ADK-L Isoforms and Their Association with CD39/CD73/A2aR in Colorectal Cancer.
Zhulai GA; Shibaev MI
Bull Exp Biol Med; 2023 Nov; 176(1):91-95. PubMed ID: 38085399
[TBL] [Abstract][Full Text] [Related]
47. The CD39
Zou F; Tan J; Liu T; Liu B; Tang Y; Zhang H; Li J
Mol Ther; 2021 May; 29(5):1794-1807. PubMed ID: 33484968
[TBL] [Abstract][Full Text] [Related]
48. Inosine-containing RNA is a novel innate immune recognition element and reduces RSV infection.
Liao JY; Thakur SA; Zalinger ZB; Gerrish KE; Imani F
PLoS One; 2011; 6(10):e26463. PubMed ID: 22028885
[TBL] [Abstract][Full Text] [Related]
49. IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype.
Alizadeh D; Wong RA; Yang X; Wang D; Pecoraro JR; Kuo CF; Aguilar B; Qi Y; Ann DK; Starr R; Urak R; Wang X; Forman SJ; Brown CE
Cancer Immunol Res; 2019 May; 7(5):759-772. PubMed ID: 30890531
[TBL] [Abstract][Full Text] [Related]
50. Deficits in endogenous adenosine formation by ecto-5'-nucleotidase/CD73 impair neuromuscular transmission and immune competence in experimental autoimmune myasthenia gravis.
Oliveira L; Correia A; Cristina Costa A; Guerra-Gomes S; Ferreirinha F; Magalhães-Cardoso MT; Vilanova M; Correia-de-Sá P
Mediators Inflamm; 2015; 2015():460610. PubMed ID: 25691808
[TBL] [Abstract][Full Text] [Related]
51. Adenosine stimulates canine retinal microvascular endothelial cell migration and tube formation.
Lutty GA; Mathews MK; Merges C; McLeod DS
Curr Eye Res; 1998 Jun; 17(6):594-607. PubMed ID: 9663849
[TBL] [Abstract][Full Text] [Related]
52. CD39/CD73/A2AR pathway and cancer immunotherapy.
Xia C; Yin S; To KKW; Fu L
Mol Cancer; 2023 Mar; 22(1):44. PubMed ID: 36859386
[TBL] [Abstract][Full Text] [Related]
53. Ectonucleotidase Expression on Human Amnion Epithelial Cells: Adenosinergic Pathways and Dichotomic Effects on Immune Effector Cell Populations.
Morandi F; Horenstein AL; Quarona V; Faini AC; Castella B; Srinivasan RC; Strom SC; Malavasi F; Gramignoli R
J Immunol; 2019 Feb; 202(3):724-735. PubMed ID: 30587530
[TBL] [Abstract][Full Text] [Related]
54. Effects of inosine on glycolysis and contracture during myocardial ischemia.
Lewandowski ED; Johnston DL; Roberts R
Circ Res; 1991 Feb; 68(2):578-87. PubMed ID: 1991356
[TBL] [Abstract][Full Text] [Related]
55. BET bromodomain protein inhibition reverses chimeric antigen receptor extinction and reinvigorates exhausted T cells in chronic lymphocytic leukemia.
Kong W; Dimitri A; Wang W; Jung IY; Ott CJ; Fasolino M; Wang Y; Kulikovskaya I; Gupta M; Yoder T; DeNizio JE; Everett JK; Williams EF; Xu J; Scholler J; Reich TJ; Bhoj VG; Haines KM; Maus MV; Melenhorst JJ; Young RM; Jadlowsky JK; Marcucci KT; Bradner JE; Levine BL; Porter DL; Bushman FD; Kohli RM; June CH; Davis MM; Lacey SF; Vahedi G; Fraietta JA
J Clin Invest; 2021 Aug; 131(16):. PubMed ID: 34396987
[TBL] [Abstract][Full Text] [Related]
56. Metabolic challenges and interventions in CAR T cell therapy.
Peng JJ; Wang L; Li Z; Ku CL; Ho PC
Sci Immunol; 2023 Apr; 8(82):eabq3016. PubMed ID: 37058548
[TBL] [Abstract][Full Text] [Related]
57. Inducible localized delivery of an anti-PD-1 scFv enhances anti-tumor activity of ROR1 CAR-T cells in TNBC.
Harrasser M; Gohil SH; Lau H; Della Peruta M; Muczynski V; Patel D; Miranda E; Grigoriadis K; Grigoriadis A; Granger D; Evans R; Nathwani AC
Breast Cancer Res; 2022 Jun; 24(1):39. PubMed ID: 35659040
[TBL] [Abstract][Full Text] [Related]
58. Oxamate enhances the efficacy of CAR-T therapy against glioblastoma via suppressing ectonucleotidases and CCR8 lactylation.
Sun T; Liu B; Li Y; Wu J; Cao Y; Yang S; Tan H; Cai L; Zhang S; Qi X; Yu D; Yang W
J Exp Clin Cancer Res; 2023 Sep; 42(1):253. PubMed ID: 37770937
[TBL] [Abstract][Full Text] [Related]
59. Non-adenosine nucleoside inosine, guanosine and uridine as promising antiepileptic drugs: a summary of current literature.
Kovacs Z; Kekesi KA; Juhasz G; Barna J; Heja L; Lakatos R; Dobolyi A
Mini Rev Med Chem; 2015; 14(13):1033-42. PubMed ID: 25382017
[TBL] [Abstract][Full Text] [Related]
60. Synergy between the ectoenzymes CD39 and CD73 contributes to adenosinergic immunosuppression in human malignant gliomas.
Xu S; Shao QQ; Sun JT; Yang N; Xie Q; Wang DH; Huang QB; Huang B; Wang XY; Li XG; Qu X
Neuro Oncol; 2013 Sep; 15(9):1160-72. PubMed ID: 23737488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
